This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between February and August 2022.
In 2019, a total of 117 881 confirmed cases of gonorrhoea were reported by 28 EU/EEA Member States. The overall crude notification rate was 31.6 cases per 100 000 population.
In 2021, 14 560 cases of hepatitis C were reported in 29 EU/EEA Member States. Excluding countries that only reported acute cases the number of cases (14 550 cases) corresponds to a crude rate of 4.1 cases per 100 000 population.
In 2021, 30 EU/EEA countries reported 3 864 cases of hepatitis A (Table 1). The EU/EEA notification rate was 0.9 cases per 100 000 population. In 2021, both the lowest number of reported cases and the lowest notification rate were reported since the beginning of EU-level hepatitis A surveillance in 2007. The total number of hepatitis A cases reported in EU/EEA countries in 2021 represented a decrease of 65.7% and 12.3% compared to 2019 and 2020, respectively.